Lascar N, Brown J, Pattison H, Barnett AH, Bailey CJ, Bellary S. Type 2 diabetes in adolescents and young adults. Lancet Diabetes Endocrinol. 2018;6:69–80.

Article  PubMed  Google Scholar 

Wu H, Patterson CC, Zhang X, et al. Worldwide estimates of incidence of type 2 diabetes in children and adolescents in 2021. Diabetes Res Clin Pract. 2022;185:109785.

Article  PubMed  Google Scholar 

RISE Consortium. Metabolic contrasts between youth and adults with impaired glucose tolerance or recently diagnosed type 2 diabetes: II. Observations using the oral glucose tolerance test. Diabetes Care. 2018;41:1707–16.

Article  Google Scholar 

RISE Consortium. Metabolic contrasts between youth and adults with impaired glucose tolerance or recently diagnosed type 2 diabetes: I. Observations using the hyperglycemic clamp. Diabetes Care. 2018;41:1696–706.

Article  Google Scholar 

Utzschneider KM, Tripputi MT, Kozedub A, et al. Differential loss of β-cell function in youth vs. adults following treatment withdrawal in the Restoring Insulin Secretion (RISE) study. Diabetes Res Clin Pract. 2021;178:108948.

Article  CAS  PubMed  PubMed Central  Google Scholar 

TODAY Study Group, Bjornstad P, Drews KL, Caprio S, et al. Long-term complications in youth-onset type 2 diabetes. N Engl J Med. 2021;385:416–26.

Article  PubMed Central  Google Scholar 

Gurunathan U, Prasad HK, White S, Sangalalingam T, Krishnamoorthy N. Type 2 diabetes mellitus in adolescents from southern India - a single center experience. Indian Pediatr. 2021;58:176–7.

Article  PubMed  PubMed Central  Google Scholar 

Dave C, Agarwal N, Patel R, Shukla R, Bajpai A. Predictors of metabolic complications in obese Indian children and adolescents. Indian J Pediatr. 2021;88:252–6.

Article  CAS  PubMed  Google Scholar 

Libman I, Haynes A, Lyons S, et al. ISPAD clinical practice consensus guidelines 2022: definition, epidemiology, and classification of diabetes in children and adolescents. Pediatr Diabetes. 2022;23:1160–74.

Article  PubMed  Google Scholar 

Shah AS, Zeitler PS, Wong J, et al. ISPAD Clinical Practice Consensus Guidelines 2022: Type 2 diabetes in children and adolescents. Pediatr Diabetes. 2022;23:872–902.

Article  PubMed  Google Scholar 

Flynn JT, Kaelber DC, Baker-Smith CM, et al. Subcommittee on Screening and Management of High Blood Pressure in Children. Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics. 2017;140:e20171904.

Article  PubMed  Google Scholar 

Khadilkar VV, Khadilkar AV. Revised Indian Academy of Pediatrics 2015 growth charts for height, weight and body mass index for 5-18-year-old Indian children. Indian J Endocrinol Metab. 2015;19:470–6.

Article  PubMed  PubMed Central  Google Scholar 

Berglund L, Brunzell JD, Goldberg AC, et al. Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012;97:2969–89.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vos MB, Abrams SH, Barlow SE, et al. NASPGHAN clinical practice guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children. J Pediatr Gastroenterol Nutr. 2017;64:319–34.

Article  PubMed  PubMed Central  Google Scholar 

Riddle MC, Cefalu WT, Evans PH, et al. Consensus report: definition and interpretation of remission in type 2 diabetes. Diabetes Care. 2021;44:2438–44.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hockett CW, Praveen PA, Ong TC, et al. Clinical profile at diagnosis with youth-onset type 1 and type 2 diabetes in two pediatric diabetes registries: SEARCH (United States) and YDR (India). Pediatr Diabetes. 2021;22:22–30.

Article  PubMed  Google Scholar 

TODAY Study Group, Zeitler P, Hirst K, Pyle L, et al. A clinical trial to maintain glycemic control in youth with type 2 diabetes. N Engl J Med. 2012;366:2247–56.

Article  PubMed Central  Google Scholar 

Tamborlane WV, Bishai R, Geller D, et al. Once-weekly exenatide in youth with type 2 diabetes. Diabetes Care. 2022;45:1833–40.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Laffel LM, Danne T, Klingensmith GJ, et al. Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in young people with type 2 diabetes (DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial. Lancet Diabetes Endocrinol. 2023;11:169–81.

Article  CAS  PubMed  PubMed Central  Google Scholar 

U.S. Food and Drug Administration, Center for Drug Evaluation and Research. NDA 022341/S-031, approval letter, 17 Jun 2019. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/022341Orig1s031ltr.pdf.

U.S. Food and Drug Administration, Center for Drug Evaluation and Research. Available at: https://www.fda.gov/news-events/press-announcements/fda-approves-new-treatment-pediatric-patients-type-2-diabetes. Accessed on 24 Jan 2024.

U.S. Food and Drug Administration, Center for Drug Evaluation and Research. Available at: https://www.fda.gov/news-events/press-announcements/fda-approves-new-class-medicines-treat-pediatric-type-2-diabetes. Accessed on 24 Jan 2024.

Sarathi V, Kolly A, Chaithanya HB, Dwarakanath CS. High rates of diabetes reversal in newly diagnosed Asian Indian young adults with type 2 diabetes mellitus with intensive lifestyle therapy. J Nat Sci Biol Med. 2017;8:60–3.

Article  PubMed  PubMed Central  Google Scholar 

Meerasa A, Dash S. Weighing in on type 2 diabetes remission. Diabetes Care. 2022;45:28–30.

Article  CAS  PubMed  Google Scholar